Announces global strategic collaboration with Astellas to advance PSMA-targeted PRO-XTEN® dual-masked T-cell engager (TCE) VIR-5500 for the treatment of prostate cancer– Reports updated VIR-5500 Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results